articleThe LancetOct 13, 2014Closed access

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Maryland Oncology Hematology · National Institutes of Health · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,935
total citations
FWCI
103.22
Percentile
100%
References
37
Citations per year

Authors

19

Topics & keywords

Keywords
  • Medicine
  • Fludarabine
  • Chimeric antigen receptor
  • Cyclophosphamide
  • Internal medicine
  • Regimen
  • CD19
  • Antigen
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding